TH
Timothy D. Henry
Elite in Angina

Dr. Timothy D. Henry

The Christ Hospital Medical Office Building
Cincinnati, OH
Elite
 in Angina
Specialties:Interventional Cardiology | Cardiology
Experience:41 Years
Clinical Trials:Currently Recruiting for 2 Trials
Accepts:New PatientsMedicare
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Timothy D. Henry's experience treating your condition:
About Dr. Timothy D. Henry

Timothy Henry is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Henry has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Heart Attack, Angina, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Bone Marrow Aspiration. He is licensed to treat patients in Minnesota. Henry is currently accepting new patients.

His clinical research consists of co-authoring 461 peer reviewed articles and participating in 16 clinical trials in the past 15 years. In particular, he has co-authored 55 articles and participated in 6 clinical trials in the study of Angina.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Timothy D. Henry it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
2123 Auburn Ave, Suite 100, Cincinnati, OH 45219
Background & Education
Graduate Institution
University Of California, San Francisco School Of Medicine, 1982
Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in MN
Hospital Affiliations
Mercy Health - West Hospital
Mercy Health - Anderson Hospital
The Christ Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Enrollment Status: Recruiting
Publish Date: December 08, 2022
Intervention Type: Device, Other
Study Phase: Not Applicable
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of NAN-101 in Subjects With NYHA Class III Heart Failure
Enrollment Status: Recruiting
Publish Date: June 04, 2021
Intervention Type: Biological
Study Drug: 3 x 10e13vg NAN-101
Study Phase: Phase 1
Health Status of Patients Enrolled in the OPTions In Myocardial Ischemic Syndrome Therapy (OPTIMIST) Program
Enrollment Status: Completed
Publish Date: December 05, 2013
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Enrollment Status: Terminated
Publish Date: October 17, 2022
Intervention Type: Biological
Study Drug: CLBS16 Granulocyte Colony-Stimulating Factor-Mobilized Autologous CD34-Positive Cells
Study Phase: Phase 2
Catheter-based Transendocardial Delivery of Autologous Bone Marrow-Derived Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Biological, Other
Study Phase: Phase 2
Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization II
Enrollment Status: Completed
Publish Date: October 28, 2016
Intervention Type: Device
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2019
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Enrollment Status: Unknown status
Publish Date: February 17, 2010
Intervention Type: Genetic, Procedure
Study Phase: Phase 1/Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization.
Enrollment Status: Completed
Publish Date: October 28, 2016
Intervention Type: Device
Study Phase: Phase 2
An Open-Label Exploratory Clinical Study to Evaluate the Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction (CMD) and Without Obstructive Coronary Artery Disease
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast Implantation by a Transendocardial Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) With Previous Placement of ICD
Enrollment Status: Unknown status
Publish Date: October 15, 2007
Intervention Type: Device, Drug
Study Drug: MyoCell™
Study Phase: Phase 1
ST Segment Detection Study
Enrollment Status: Terminated
Publish Date: February 18, 2019
Intervention Type: Device
A Prospective, Double-Blind, Randomized, Placebo-controlled Clinical Trial of Intracoronary Infusion of Mesenchymal Precursor Cells (MPC) in the Treatment of Patients With ST-Elevation Myocardial Infarction
Enrollment Status: Completed
Publish Date: June 23, 2022
Intervention Type: Other, Biological
Study Drugs: 12.5 M Mesenchymal Precursor Cells (MPC)25M Mesenchymal Precursor Cells (MPC)
Study Phase: Phase 2
Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study
Enrollment Status: Not yet recruiting
Publish Date: November 01, 2019
Intervention Type: Combination Product
Study Drug: Human Recombinant Fibroblast Growth Factor-1
Study Phase: Phase 2
View 13 Less Clinical Trials -
461 Total Publications
Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021.
Journal: JAMA
Published: November 06, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
DK
Dean J. Kereiakes
Dr. Dean J. Kereiakes
Interventional Cardiology | Cardiology
Distinguished
Highly rated in
38
conditions
Interventional Cardiology
Cardiology

Christ Hospital System

The Christ Hospital Outpatient Center - Red Bank

4440 Red Bank Rd, 
Cincinnati, OH 
 6.2 mi

Dean Kereiakes is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Kereiakes has been practicing medicine for over 45 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 38 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Aortic Valve Stenosis, Stent Placement, and Percutaneous Coronary Intervention (PCI). He is licensed to treat patients in Ohio. Kereiakes is currently accepting new patients.

MS
Dr. Matthew K. Shotwell
Interventional Cardiology | Cardiology
Distinguished
Highly rated in
27
conditions
Interventional Cardiology
Cardiology

HMH Physician Group- Cardiology Services

Cynthiana, KY 
 52.5 mi

Matthew Shotwell is an Interventional Cardiologist and a Cardiologist in Cynthiana, Kentucky. Shotwell has been practicing medicine for over 29 years and is rated as a Distinguished expert by MediFind in the treatment of Angina. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Pacemaker Implantation, and Angioplasty. He is licensed to treat patients in Ohio and Kentucky. Shotwell is currently accepting new patients.

JS
Dr. Jerome B. Schutzman
Interventional Cardiology | Cardiology
Distinguished
Highly rated in
25
conditions
Interventional Cardiology
Cardiology

St Elizabeth Healthcare

Heart & Vascular - Edgewood Heart & Vascular Institute

711 Medical Village Dr, 
Edgewood, KY 
 8.3 mi

Jerome Schutzman is an Interventional Cardiologist and a Cardiologist in Edgewood, Kentucky. Schutzman has been practicing medicine for over 35 years and is rated as a Distinguished expert by MediFind in the treatment of Angina. He is also highly rated in 25 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, and High Cholesterol. He is licensed to treat patients in Indiana and Kentucky. Schutzman is currently accepting new patients.